NanoenTek,Inc.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
As of 2026-10-10, NanoenTek,Inc. has 119 Korean MFDS device approvals, 17 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- Lab-On-a-Chip (LOC) diagnostic platformIn-vitro diagnostic device for clinical screening such as cancer diagnosis and white/red blood cell counting
- Life science instruments and consumablesCell-counting equipment and related consumables for life science experiments
Regulatory approvals
data.go.kr119 Korean MFDS device approvals · 2001–2026
- MFDSOther Reagents, classⅡ, for clinical chemistry2026-04-24Product approval · Class 2체외 제인 26-4365 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2026-04-21Product approval · Class 2체외 제인 26-4348 호
- MFDSIVD Reagents for thyroid function hormone tests2025-11-12Product approval · Class 2체외 제인 25-5049 호
- MFDSIVD Reagents for thyroid function hormone tests2024-10-15Product approval · Class 2체외 제인 24-941 호
- MFDSFluorimetric immunoassay analyzer(FIA), stationary2024-04-29Product approval · Class 1체외 제신 24-530 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-03-16Product approval · Class 3체외 제허 23-425 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2023-03-13Product approval · Class 3체외 제허 23-341 호
- MFDSIVD reagents for inflammatory tests2022-11-29Product approval · Class 2체외 제인 22-4926 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2022-10-19Product approval · Class 3체외 제허 22-702 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2022-01-24Product approval · Class 3체외 제허 22-48 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2021-10-05Product approval · Class 3체외 제허 21-827 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-06-25Product approval · Class 3체외 제허 21-527 호
Show 68 more
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2020-11-18Product approval · Class 3체외 제허 20-975 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-11-16Product approval · Class 3체외 제허 20-966 호
- MFDSIVD reagents for inflammatory tests2020-10-06Product approval · Class 2체외 제인 20-4909 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-10-05Product approval · Class 3체외 제허 20-855 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2020-10-05Product approval · Class 3체외 제허 20-854 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-09-09Product approval · Class 3체외 제허 20-791 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-08-28Product approval · Class 3체외 제허 20-759 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2020-08-14Product approval · Class 3체외 제허 20-656 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2020-08-14Product approval · Class 3체외 제허 20-655 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2020-08-14Product approval · Class 3체외 제허 20-654 호
- MFDSGeneral Calibrators, controls or standards, classⅡ, for clinical immunology, not a component of specific kit, wide use2020-08-03Product approval · Class 2체외 제인 20-4700 호
- MFDSGeneral Calibrators, controls or standards, classⅡ, for clinical immunology, not a component of specific kit, wide use2020-08-03Product approval · Class 2체외 제인 20-4698 호
- MFDSGeneral Calibrators, controls or standards, classⅡ, for clinical immunology, not a component of specific kit, wide use2020-08-03Product approval · Class 2체외 제인 20-4699 호
- MFDSIVD reagents for flow cytometric test2020-07-22Product approval · Class 2체외 제인 20-4654 호
- MFDSGeneral Calibrators, controls or standards, classⅢ, for clinical immunology, not a component of specific kit, wide use2020-06-30Product approval · Class 3체외 제허 20-525 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2020-06-10Product approval · Class 3체외 제허 20-461 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-04-20Product approval · Class 3체외 제허 20-296 호
- MFDSHematology analyzer, cell-quantifying2020-03-19Product approval · Class 1체외 제신 20-360 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-02-18Product approval · Class 3체외 제허 20-129 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-02-06Product approval · Class 3체외 제허 20-97 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-02-06Product approval · Class 3체외 제허 20-96 호
- MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, immunological method2020-01-09Product approval · Class 4체외 제허 20-22 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-01-09Product approval · Class 3체외 제허 20-21 호
- MFDSHematology analyzer, cell-quantifying2019-07-08Product approval · Class 1체외 제신 19-918 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2019-06-13Product approval · Class 1체외 제신 19-775 호
- MFDSIVD reagents for diagnostic blood coagulation test2019-03-15Product approval · Class 3체외 제허 19-157 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2018-09-20Product approval · Class 1체외 제신 18-1266 호
- MFDSHematology analyzer, cell-quantifyingRevoked2018-06-15Product approval · Class 1체외 제신 18-729 호
- MFDSOther Reagents, classⅡ, for clinical chemistry2018-02-14Product approval · Class 2체외 제인 18-4123 호
- MFDSIVD reagents for hematological stains2017-08-10Product approval · Class 1체외 제신 17-919 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2017-07-03Product approval · Class 1체외 제신 17-771 호
- MFDSHematology analyzer, cell-quantifying2016-12-20Product approval · Class 1체외 제신 16-1493 호
- MFDSTool for specimens2016-11-23Product approval · Class 1수신 16-2976 호
- MFDSIVD reagents for extracting nucleic acids2016-11-02Product approval · Class 1체외 제신 16-1303 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2016-07-04Product approval · Class 1체외 제신 16-816 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2016-07-04Product approval · Class 1체외 제신 16-818 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2016-07-01Product approval · Class 1체외 제신 16-812 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2016-07-01Product approval · Class 1체외 제신 16-814 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2016-07-01Product approval · Class 1체외 제신 16-813 호
- MFDSIVD reagents for general immune test2016-04-22Product approval · Class 2체외 제인 16-312 호
- MFDSIVD reagents for general immune test2016-04-22Product approval · Class 2체외 제인 16-313 호
- MFDSHematology analyzer, cell-quantifying2016-04-20Product approval · Class 1체외 제신 16-482 호
- MFDSIVD reagents for flow cytometric testRevoked2016-04-15Product approval · Class 2체외 제허 16-297 호
- MFDSIVD Reagents for thyroid function hormone tests2016-02-12Product approval · Class 2체외 제인 16-104 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2016-01-22Product approval · Class 3체외 제허 16-39 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2016-01-22Product approval · Class 3체외 제허 16-40 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2015-12-11Product approval · Class 3체외 제허 15-1667 호
- MFDSIVD reagents for infectious inflammatory tests2015-11-12Product approval · Class 2체외 제인 15-1573 호
- MFDSIVD Reagents for thyroid function hormone tests2015-11-12Product approval · Class 2체외 제인 15-1574 호
- MFDSBlood sample preparation instruments, general2015-09-25Product approval · Class 1체외 제신 15-171 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2015-09-25Product approval · Class 3체외 제허 15-1441 호
- MFDSDry type clinical chemistry automated analyzer2015-08-19Product approval · Class 1체외 제신 15-62 호
- MFDSIVD reagents for diagnosis of HIV, HBV, HCV, HTLV, immunological method2015-07-27Product approval · Class 4체외 제허 15-1237 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2015-07-22Product approval · Class 1경인 체외 제신 15-394 호
- MFDSIVD Reagents for pregnancy/childbirth hormone and protein tests2015-07-06Product approval · Class 2체외 제인 15-1084 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2015-05-06Product approval · Class 3체외 제허 15-689 호
- MFDSFluorimetric immunoassay analyzer(FIA), stationary2015-04-16Product approval · Class 1경인 체외 제신 15-173 호
- MFDSIVD reagents for neurosecretion functionRevoked2015-04-16Product approval · Class 2체외 제인 15-576 호
- MFDSDry type clinical chemistry automated analyzerRevoked2015-04-14Product approval · Class 1경인 체외 제신 15-168 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2015-03-30Product approval · Class 3체외 제허 15-441 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2015-03-30Product approval · Class 3체외 제허 15-442 호
- MFDSGeneral calibrators, controls or standards, classⅠ, for clinical chemistryRevoked2014-12-16Product approval · Class 1서울 체외 수신 14-3103 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2014-12-15Product approval · Class 3체외 제허 14-3046 호
- MFDSIVD reagents for tumor marker2014-11-27Product approval · Class 3체외 제허 14-2638 호
- MFDSIVD reagents for cardiac markerRevoked2014-11-27Product approval · Class 3체외 제허 14-2639 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2014-11-24Product approval · Class 3체외 제허 14-2399 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2014-11-24Product approval · Class 3체외 제허 14-2400 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2014-11-24Product approval · Class 3체외 제허 14-2404 호
Showing the 80 most recent of 119 records.
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Development of Monitoring System for Assessing Rheumatoid Arthritis within 5 Minutes Using a Drop of Bio-Fluids.
Journal of clinical medicine · 2020-10 · Koh JH, Lee S, Kim HS 외 5
- Enumeration of CD34-positive Stem Cells Using the ADAMII Image-based Fluorescence Cell Counter.
Annals of laboratory medicine · 2019-07 · Yu H, Yoo J, Hwang JS 외 9
- Development of an anti-EPO antibody detection kit based on lab-on-a-chip and bridging antibody technologies.
Biologicals : journal of the International Association of Biological Standardization · 2018-07 · Oh JG, Seong J, Han S 외 1
- Correction to: HiComet: a high-throughput comet analysis tool for large-scale DNA damage assessment.
BMC bioinformatics · 2018-05 · Lee T, Lee S, Sim WY 외 5
- HiComet: a high-throughput comet analysis tool for large-scale DNA damage assessment.
BMC bioinformatics · 2018-02 · Lee T, Lee S, Sim WY 외 5
- Performance evaluation of an automated image-based fluorescence CD4+ cell analyzer.
Technology and health care : official journal of the European Society for Engineering and Medicine · 2018-01 · Cho MO, Kim S, Lee JY 외 5
- Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time.
OncoTargets and therapy · 2016-01 · Baek N, Seo OW, Kim M 외 2
- Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.
Drug design, development and therapy · 2016-01 · Baek N, Seo OW, Lee J 외 2
- Detection of platelet-monocyte aggregates by the ADAM(®) image cytometer.
International journal of medical sciences · 2014-01 · Jung BK, Cho CH, Moon KC 외 3
- Measurement of RBC agglutination with microscopic cell image analysis in a microchannel chip.
Clinical hemorheology and microcirculation · 2014-01 · Cho CH, Kim JY, Nyeck AE 외 6
Show 7 more publications
- Nanoparticle-based diagnostic imaging of inflammation in rheumatic disease.
Current rheumatology reviews · 2014-01 · Rogers JL, Tarrant T, Kim JS
- Titania on the brain.
Nanomedicine (London, England) · 2011-04 · Kim JS, Kang M, Bagyinszky E 외 1
- Mimicking red blood cells for drug delivery.
Nanomedicine (London, England) · 2011-04 · Kim JS, Kang M, Bagyinszky E 외 2
- FeCo/graphite nanocrystals for vascular inflammation imaging.
Nanomedicine (London, England) · 2011-04 · Kim JS, Kang M, Bagyinszky E 외 2
- Combining microfluidics with nanocrystals for clinical diagnostics.
Nanomedicine (London, England) · 2011-04 · Kim JS, Kang M, Bagyinszky E 외 2
- Ongoing development of image cytometers.
Bioanalysis · 2010-10 · Kim JS, Hur D, Hwang JK 외 2
- A novel electroporation method using a capillary and wire-type electrode.
Biosensors & bioelectronics · 2008-04 · Kim JA, Cho K, Shin MS 외 4
Patents
KIPRIS · applicant-matchedUS · Published · 2026-01 · Application 19442169
US · Published · 2023-09 · Application 19108175
EP · Published · 2023-09 · Application 23863514.8
PCT · Published · 2023-09 · Application PCT/KR2023/013378
Registered · 2023-09 · Application 1020230117940
CN · Published · 2022-01 · Application 202280011182.5
US · Registered · 2022-01 · Application 18270795
EP · Published · 2022-01 · Application 22742916.4
PCT · Published · 2022-01 · Application PCT/KR2022/001294
Registered · 2022-01 · Application 1020220010747
Show 117 more patents
CN · Published · 2021-03 · Application 202180021754.3
US · Published · 2021-03 · Application 17911600
EP · Published · 2021-03 · Application 21772405.3
PCT · Published · 2021-03 · Application PCT/KR2021/002976
Registered · 2020-03 · Application 1020200032732
CN · Published · 2016-08 · Application 201680051212.X
CN · Published · 2016-08 · Application 201680050579.X
US · Registered · 2016-08 · Application 15757551
US · Registered · 2016-08 · Application 15757523
EP · Registered · 2016-08 · Application 16842246.7
EP · Registered · 2016-08 · Application 16842245.9
PCT · Published · 2016-08 · Application PCT/KR2016/009641
PCT · Published · 2016-08 · Application PCT/KR2016/009640
Registered · 2016-08 · Application 1020160107601
Registered · 2015-09 · Application 1020150125867
CN · Published · 2015-05 · Application 201580027380.0
US · Registered · 2015-05 · Application 15313382
EP · Registered · 2015-05 · Application 15795399.3
PCT · Published · 2015-05 · Application PCT/KR2015/005191
CN · Published · 2015-05 · Application 201580029437.0
US · Published · 2015-05 · Application 15313757
EP · Published · 2015-05 · Application 15803252.4
PCT · Published · 2015-05 · Application PCT/KR2015/004865
US · Published · 2014-11 · Application 14555299
PCT · Published · 2014-07 · Application PCT/KR2014/006515
Registered · 2014-06 · Application 1020140067508
Registered · 2014-05 · Application 1020140062143
PCT · Published · 2014-03 · Application PCT/KR2014/002735
CN · Published · 2013-09 · Application 201380046442
US · Published · 2013-09 · Application 14425333
EP · Published · 2013-09 · Application 13835710.8
PCT · Published · 2013-09 · Application PCT/KR2013/008029
US · Registered · 2013-05 · Application 14401140
EP · Published · 2013-05 · Application 13790198.9
PCT · Published · 2013-05 · Application PCT/KR2013/004263
Abandoned · 2013-04 · Application 1020130040248
CN · Published · 2013-02 · Application 201380010090
US · Registered · 2013-02 · Application 14379664
EP · Registered · 2013-02 · Application 13751527.6
PCT · Published · 2013-02 · Application PCT/KR2013/001340
US · Published · 2013-01 · Application 14369896
PCT · Published · 2013-01 · Application PCT/KR2013/000025
PCT · Published · 2012-12 · Application PCT/KR2012/010644
Expired · 2012-09 · Application 1020120099447
Withdrawn · 2012-05 · Application 1020120058644
EP · Published · 2012-05 · Application 12800355.5
PCT · Published · 2012-05 · Application PCT/KR2012/003806
Registered · 2012-05 · Application 1020120050704
Registered · 2012-02 · Application 1020120017039
Expired · 2012-01 · Application 1020120000493
PCT · Published · 2011-12 · Application PCT/KR2011/009258
EP · Published · 2011-08 · Application 11818416.7
PCT · Published · 2011-08 · Application PCT/KR2011/006084
Registered · 2011-08 · Application 1020110082148
Expired · 2011-06 · Application 1020110057420
EP · Published · 2011-05 · Application 11786904.0
PCT · Published · 2011-05 · Application PCT/KR2011/003843
Expired · 2011-05 · Application 1020127020306
US · Published · 2011-05 · Application 13698697
PCT · Published · 2011-05 · Application PCT/KR2011/003658
CN · Published · 2011-04 · Application 201110132696
EP · Registered · 2011-04 · Application 11161144.8
PCT · Published · 2011-04 · Application PCT/KR2011/002328
Registered · 2011-03 · Application 1020110024921
CN · Published · 2011-03 · Application 201180013646
EP · Published · 2011-03 · Application 11753628.4
PCT · Published · 2011-03 · Application PCT/KR2011/001680
PCT · Published · 2011-01 · Application PCT/KR2011/000435
Rejected · 2011-01 · Application 1020110006155
US · Published · 2010-11 · Application 13512319
EP · Published · 2010-11 · Application 10836158.5
PCT · Published · 2010-11 · Application PCT/KR2010/008448
Withdrawn · 2010-11 · Application 1020100107640
Withdrawn · 2010-10 · Application 1020100101259
Registered · 2010-05 · Application 1020100047904
Expired · 2010-05 · Application 1020100046257
EP · Published · 2010-05 · Application 10162173.8
Registered · 2010-04 · Application 1020100030995
Expired · 2010-03 · Application 1020100022124
PCT · Published · 2010-02 · Application PCT/KR2010/000758
Withdrawn · 2009-12 · Application 1020090132409
Rejected · 2009-12 · Application 1020090131901
Withdrawn · 2009-12 · Application 1020090130139
Withdrawn · 2009-12 · Application 1020090130131
Expired · 2009-12 · Application 1020090123007
Expired · 2009-11 · Application 1020090105069
Expired · 2009-11 · Application 1020090105062
Expired · 2009-11 · Application 1020090105063
Expired · 2009-10 · Application 1020090104256
Expired · 2009-10 · Application 1020090097893
Rejected · 2009-07 · Application 1020090063356
EP · Registered · 2008-11 · Application 08852470.7
EP · Registered · 2008-07 · Application 08792868.5
Withdrawn · 2008-05 · Application 1020080045099
Expired · 2007-11 · Application 1020097007294
Expired · 2007-06 · Application 1020070063126
Expired · 2007-06 · Application 1020070059093
Expired · 2007-06 · Application 2020070009360
Expired · 2006-06 · Application 1020060052090
Expired · 2006-04 · Application 1020060033525
Expired · 2006-04 · Application 1020060033524
EP · Registered · 2004-07 · Application 04748430.8
Expired · 2004-04 · Application 1020040026184
Rejected · 2003-07 · Application 1020030052583
Expired · 2003-04 · Application 1020030022207
Rejected · 2002-11 · Application 1020020070277
Withdrawn · 2002-04 · Application 1020020021767
Expired · 2001-06 · Application 1020010032897
Expired · 2001-03 · Application 2020010007087
Expired · 2001-03 · Application 1020010013448
Expired · 2000-05 · Application 2020000015161
Expired · 1998-09 · Application 1019980037426
Rejected · 1997-10 · Application 1019970052810
Expired · 1997-10 · Application 1019970052809
Rejected · 1997-10 · Application 1019970051233
Expired · 1997-10 · Application 1019970051232
Expired · 1996-08 · Application 1019960034877
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot148
- GoogleGoogleOther31
- PerplexityPerplexityBot11
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for NanoenTek,Inc. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition